专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20210005765A1 THIN FILM TYPE SOLAR CELL AND METHOD FOR MANUFACTURING THE SAME 有权
公开(公告)号：US20210005765A1
公开(公告)日：2021-01-07
申请号：US13877333
申请日：2011-09-21
申请人： Jun Ki MIN , Sang Su CHOI
发明人： Jun Ki MIN , Sang Su CHOI
IPC分类号： H01L31/0465 , H01L31/0224 , H01L31/18
摘要： Disclosed is a thin film type solar cell with superior efficiency and a method for manufacturing the same.
The thin film type solar cell includes a substrate, one or more front electrodes arranged on the substrate such that the front electrodes are spaced from one another through a first trench, a semiconductor layer arranged on the front electrode, wherein a part of the semiconductor layer is removed by a second trench adjacent to the first trench, and one or more rear electrodes arranged on the second trench and the semiconductor layer such that the rear electrodes are spaced from one another through a third trench adjacent to the second trench, wherein the semiconductor layer include one or more connection members which are adjacent to the second trench and are divided by the second trench.
Based on such configuration, the thin film type solar cell and the method for manufacturing the same provide superior photoelectric transformation efficiency by connecting semiconductor layers arranged at both sides of the second trench through the connection member.

2. 发明授权

US09301954B2 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient 有权
标题翻译：用于预防或治疗含有瑞巴派特作为活性成分的骨关节炎的药物组合物
公开(公告)号：US09301954B2
公开(公告)日：2016-04-05
申请号：US13582929
申请日：2011-03-04
申请人： Jun-Ki Min , Mi-La Cho , Yun-Ju Woo , Hye-Jwa Oh , Young-Ok Jung , Geun-Hyeog Lee , Byong-Sun Choi , Jin-Ha Park , Eun-Young Kwak
发明人： Jun-Ki Min , Mi-La Cho , Yun-Ju Woo , Hye-Jwa Oh , Young-Ok Jung , Geun-Hyeog Lee , Byong-Sun Choi , Jin-Ha Park , Eun-Young Kwak
IPC分类号： A01N43/42 , A61K31/47 , A61K31/4704 , A61K9/20
CPC分类号： A61K31/4704 , A61K9/2004
摘要： The present invention provides a method for preventing or treating osteoarthritis comprising administrating rebamipide or a pharmaceutical composition comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier to a subject in need thereof. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
摘要翻译：本发明提供了一种预防或治疗骨关节炎的方法，其包括向有需要的受试者施用瑞巴派特或包含瑞巴派特作为活性成分和药学上可接受的载体的药物组合物。药物组合物可用于口服给药，例如片剂或胶囊形式的口服固体剂型。药物组合物可以配制成适于以0.5至50mg / kg，优选0.6至6mg / kg的剂量口服施用瑞巴派特的单位剂型。

3. 发明申请

US20120172394A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS, CONTAINING REBAMIPIDE 有权
标题翻译：用于预防或治疗含有雷贝匹丁的湿疹风湿性关节炎药物组合物
公开(公告)号：US20120172394A1
公开(公告)日：2012-07-05
申请号：US13392197
申请日：2009-10-08
申请人： Jun-Ki Min , Mi-La Cho , Yun-Ju Woo , Hye-Jwa Oh , Joo-Yeon Jhun , Geun-Hyeog Lee , Se-Wan Park , Jin-Ha Park , Eun-Young Kwak
发明人： Jun-Ki Min , Mi-La Cho , Yun-Ju Woo , Hye-Jwa Oh , Joo-Yeon Jhun , Geun-Hyeog Lee , Se-Wan Park , Jin-Ha Park , Eun-Young Kwak
IPC分类号： A61K31/4704 , A61P29/00
CPC分类号： A61K31/4704
摘要： The present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
摘要翻译：本发明提供了一种用于预防或治疗类风湿性关节炎的药物组合物，其包含瑞巴派特作为活性成分和药学上可接受的载体。药物组合物可用于口服给药，例如片剂或胶囊形式的口服固体剂型。药物组合物可以配制成适于以0.5至50mg / kg，优选0.6至6mg / kg的剂量口服施用瑞巴派特的单位剂型。

4. 发明授权

US08981713B2 Charging apparatus using pad type electrode contact point 有权
标题翻译：充电装置采用垫式电极接触点
公开(公告)号：US08981713B2
公开(公告)日：2015-03-17
申请号：US13600078
申请日：2012-08-30
申请人： Kwang Du Lee , Eung Ju Kim , Sang Hoon Hwang , Jun Ki Min , Chul Gyun Park
发明人： Kwang Du Lee , Eung Ju Kim , Sang Hoon Hwang , Jun Ki Min , Chul Gyun Park
IPC分类号： H02J7/00 , H02G3/00 , H02K7/14 , G01R19/14 , H02J7/16 , H02J7/04
CPC分类号： H02J7/0045 , H02G3/00 , H02J7/00 , H02J7/04 , H02J7/16 , H02K7/14
摘要： Disclosed herein is a charging apparatus using a pad type electrode contact point, the charging apparatus including: a charging plate having a plate shape; and an attaching plate installed on a portable terminal to provide the power to a charging circuit of the portable terminal.
摘要翻译：这里公开了一种使用焊盘型电极接触点的充电装置，该充电装置包括：具有板形的充电板; 以及安装在便携式终端上以将便携式终端的充电电路供电的安装板。

5. 发明授权

US08691842B2 Pharmaceutical composition for preventing or treating rheumatoid arthritis, containing rebamipide 有权
标题翻译：用于预防或治疗类风湿性关节炎的药物组合物，含有瑞巴派特
公开(公告)号：US08691842B2
公开(公告)日：2014-04-08
申请号：US13392197
申请日：2009-10-08
申请人： Jun-Ki Min , Mi-La Cho , Yun-Ju Woo , Hye-Jwa Oh , Joo-Yeon Jhun , Geun-Hyeog Lee , Se-Wan Park , Jin-Ha Park , Eun-Young Kwak
发明人： Jun-Ki Min , Mi-La Cho , Yun-Ju Woo , Hye-Jwa Oh , Joo-Yeon Jhun , Geun-Hyeog Lee , Se-Wan Park , Jin-Ha Park , Eun-Young Kwak
IPC分类号： A01N43/42 , A61K31/47 , A61K9/14 , A01N43/06 , A61K31/38
CPC分类号： A61K31/4704
摘要： The present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
摘要翻译：本发明提供了一种用于预防或治疗类风湿性关节炎的药物组合物，其包含瑞巴派特作为活性成分和药学上可接受的载体。药物组合物可用于口服给药，例如片剂或胶囊形式的口服固体剂型。药物组合物可以配制成适于以0.5至50mg / kg，优选0.6至6mg / kg的剂量口服施用瑞巴派特的单位剂型。

6. 发明授权

US08620369B2 Channel access method in wireless network 有权
标题翻译：无线网络中的信道接入方式
公开(公告)号：US08620369B2
公开(公告)日：2013-12-31
申请号：US13233720
申请日：2011-09-15
申请人： Sung Ho Hwang , Ki Hong Kim , Jun Ki Min
发明人： Sung Ho Hwang , Ki Hong Kim , Jun Ki Min
IPC分类号： H04B7/00
CPC分类号： H04W74/0816
摘要： There is provided a channel access method in which a channel access method in a wireless network in which a channel access opportunity is provided to high priority traffic for each super-frame. The channel access method includes: setting parameter values required for channel access; setting a channel access time to be equal to a size of a contention access period (CAP); and accessing a channel to be used by resetting the channel access time to be equal to the size of the CAP when traffic to be transmitted is traffic having a preset high priority in a case in which the channel is not in an idle state.
摘要翻译：提供了一种信道接入方法，其中无线网络中的信道接入方法，其中为每个超帧向高优先级业务提供信道接入机会。通道访问方式包括：设置通道访问所需的参数值; 将通道访问时间设置为等于争用访问时段（CAP）的大小; 以及在频道不处于空闲状态的情况下，要发送的业务量为具有预先设定的高优先级的业务的业务时，通过将所述信道接入时间重新设置为等于所述CAP的大小来访问要使用的信道。

7. 发明申请

US20130065920A1 PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF OSTEOARTHRITIS CONTAINING REBAMIPIDE AS AN ACTIVE INGREDIENT 有权
标题翻译：用于预防或治疗含有作为活性成分的雷贝匹汀的骨质疏松症的药物组合物
公开(公告)号：US20130065920A1
公开(公告)日：2013-03-14
申请号：US13582929
申请日：2011-03-04
申请人： Jun-Ki Min , Mi-La Cho , Yun-Ju Woo , Hye-Jwa Oh , Young-Ok Jung , Geun-Hyeog Lee , Byong-Sun Choi , Jin-Ha Park , Eun-Young Kwak
发明人： Jun-Ki Min , Mi-La Cho , Yun-Ju Woo , Hye-Jwa Oh , Young-Ok Jung , Geun-Hyeog Lee , Byong-Sun Choi , Jin-Ha Park , Eun-Young Kwak
IPC分类号： A61K31/4704 , A61P19/02
CPC分类号： A61K31/4704 , A61K9/2004
摘要： The present invention provides a pharmaceutical composition for preventing or treating osteoarthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
摘要翻译：本发明提供了一种用于预防或治疗骨关节炎的药物组合物，其包含雷巴米特作为活性成分和药学上可接受的载体。药物组合物可用于口服给药，例如片剂或胶囊形式的口服固体剂型。药物组合物可以配制成适于以0.5至50mg / kg，优选0.6至6mg / kg的剂量口服施用瑞巴派特的单位剂型。

8. 发明授权

US08014466B2 Wide-band direct conversion transmission apparatus 有权
标题翻译：宽带直接转换传输装置
公开(公告)号：US08014466B2
公开(公告)日：2011-09-06
申请号：US12194896
申请日：2008-08-20
申请人： Jun Ki Min , Jong Sik Kim , Hyun Chol Shin , Jeong Suk Lee
发明人： Jun Ki Min , Jong Sik Kim , Hyun Chol Shin , Jeong Suk Lee
IPC分类号： H04L27/00
CPC分类号： H04L27/12
摘要： There is provided a wide-band direct conversion transmitting apparatus including: a local oscillation unit generating first, second, and third oscillation signal pairs each including a pair of signals having a phase difference of 90°; an image rejection mixer unit mixing baseband transmission signals including an I signal and a Q signal having a phase difference of 90° with the first oscillation signal pair; a harmonic rejection mixer unit mixing each of the first, second, and third oscillation signal pairs with the baseband transmission signals; and an output signal selecting unit selecting output signals from the image rejection mixer unit or from the harmonic rejection mixer unit.
摘要翻译：提供了一种宽带直接转换发送装置，包括：本地振荡单元，其产生第一，第二和第三振荡信号对，每个振荡信号对包括相位差为90°的一对信号; 镜像抑制混频器单元将包括I信号和90°相位差的Q信号的基带传输信号与第一振荡信号对混合; 谐波抑制混频器单元，将第一，第二和第三振荡信号对中的每一个与基带传输信号混合; 以及输出信号选择单元，选择来自镜像抑制混频器单元或谐波抑制混频器单元的输出信号。

9. 发明申请

US20100173028A1 PROCESS FOR PREPARING VITIS VINIFERA PIP EXTRACT AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING RHEUMATOID ARTHRITIS COMPRISING THE SAME 审中-公开
标题翻译：制备VITIS VINIFERA PIP萃取物和药物组合物的方法，用于预防或治疗包含其中的RHEUMATOID ARTHRITIS
公开(公告)号：US20100173028A1
公开(公告)日：2010-07-08
申请号：US12733461
申请日：2008-09-04
申请人： Jun-Ki Min , Mi-La Cho , Mi-Kyung Park , Yu-Jung Heo , Jin-Sil Park , Ho-Youn Kim , Jong-Hyeon Ryu , Hyun-Gyu Kim , Geun-Hyeog Lee
发明人： Jun-Ki Min , Mi-La Cho , Mi-Kyung Park , Yu-Jung Heo , Jin-Sil Park , Ho-Youn Kim , Jong-Hyeon Ryu , Hyun-Gyu Kim , Geun-Hyeog Lee
IPC分类号： A61K36/87 , A61K31/353 , A61P29/00
CPC分类号： A61K36/87
摘要： The present invention provides an improved process for preparing a Vitis vinifera pip extract. And also, the present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis including the Vitis vinifera pip extract as an active ingredient.
摘要翻译：本发明提供了一种用于制备葡萄汁提取物的改进方法。而且，本发明提供了用于预防或治疗类风湿性关节炎的药物组合物，其包括葡萄汁提取物作为活性成分。

10. 发明授权

US07539692B2 Method of performing queriable XML compression using reverse arithmetic encoding and type inference engine 失效
标题翻译：使用反向算术编码和类型推理引擎执行可疑XML压缩的方法
公开(公告)号：US07539692B2
公开(公告)日：2009-05-26
申请号：US10860292
申请日：2004-06-03
申请人： Jun-Ki Min , Myung-Jae Park , Chin-Wan Chung
发明人： Jun-Ki Min , Myung-Jae Park , Chin-Wan Chung
IPC分类号： G06F17/30
CPC分类号： G06F17/2205 , Y10S707/99942
摘要： A method and apparatus for performing queriable XML compression and queries related to a compressed XML document are disclosed. In the method, information, including at least the frequencies of the respective tags of XML data, the type information of data values and data value-related statistical information is collected. Thereafter, the type information of data values of elements is inferred according to tags using an automatic data type inference engine algorithm. Reverse arithmetic encoding is performed on the tags and paths of elements. The data values are encoded based on the inferred type information.
摘要翻译：公开了一种用于执行可压缩XML压缩和与压缩XML文档相关的查询的方法和装置。在该方法中，收集至少包括XML数据的各个标签的频率，数据值的类型信息和与数据值相关的统计信息的信息。此后，使用自动数据类型推理引擎算法，根据标签推断元素的数据值的类型信息。对元素的标签和路径执行反向算术编码。基于推断的类型信息对数据值进行编码。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式